Media Thread, page-15396

First 15396 Last

Share
Profile

Follow
plumvj

762 Posts.

143

05/09/24

07:55

Post #: 75535425
Share

Originally posted by Taureanbull: ↑

Reon, I see it differently than you do. My take is that we have a product now that is safe and tolerable and highly effective which is on track to be trialled in 15-20 pax. The results of this trial will be released 1H25.

Prior to these results we will have early data for Oncarlytics and. a major update for Vaxinia z

We are well and truly on track to know if we are sitting on the best advancement in Oncoligy out there.

IMU is then well and truly a prime target for a takeover or major trade sale. From that point forward there is a major risk to be sitting on the sidelines for shareholders because our first warning will be a trading halt.

If the shareprice fails to move after all of that progress, and current shareholders who do understand the underlying value of y to be assets can confidently buy up really big. Because the science will all be derisked ,

Paul Woodard was correct in saying the trials are going well. There is obviously a demand for this treatment with 15 major sites open in the US and 5 more opening in Australia. We are only needing 15 more pax. There are patients being evaluated now.

I missed some of the webinar and willl watch again today. But LC said the market size is conservatively $2.5bn. And that was only the refractory o ok patients who failed other CarT’s. Once Oncologist get there hands on Azer-Cel it will be first line of treatment. Off label usage will ensure that happens. LC did mention more indications.

None of this will be lost on those US investors and Big Pharma that LC talks to on her regular trips .

The ASX might not recognise the revolutionary treatments being developed here, so the SP wallows but that’s what is called opportunity for the sharp punter.

Expand

agree to disagree TB
if we get good results on onCart and Vaxinia and the shareprice fails to move after all of that progress,
then there is a problem

IMU Price at posting: 5.9¢ Sentiment: Hold Disclosure: Held
4 Upvote

0 Great analysis

Reply

Top Stories

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

3DA

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

PR1

Nanocap Pure Resources acquires Reedy Creek garnet project, WA

Trump is President Again: What Does This Mean for Crypto?

PRS

Prospech finds dynamite heavy REE grades from historic core in Finland

First 15396 Last

Add IMU (ASX) to my watchlist

(20min delay)
Last 4.8¢		Change 0.002(4.35%)		Mkt cap ! $357.0M

Open	High	Low	Value	Volume
4.7¢	4.9¢	4.6¢	$977.7K	20.56M

Buyers (Bids)

No.	Vol.	Price($)
13	3232340	4.7¢

Sellers (Offers)

Price($)	Vol.	No.
4.8¢	854027	4

View Market Depth

No.	Vol.	Price($)
13	3232340	0.047
21	4498330	0.046
33	7014309	0.045
37	6583493	0.044
30	3316810	0.043

Price($)	Vol.	No.
0.048	854027	4
0.049	3622300	15
0.050	6027470	18
0.051	2006954	12
0.052	2391989	13

Last trade - 16.10pm 11/11/2024 (20 minute delay)

IMU (ASX) Chart

Media Thread, page-15396

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Nanocap Pure Resources acquires Reedy Creek garnet project, WA

Trump is President Again: What Does This Mean for Crypto?

Prospech finds dynamite heavy REE grades from historic core in Finland

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Media Thread, page-15396

Top Stories

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Nanocap Pure Resources acquires Reedy Creek garnet project, WA

Trump is President Again: What Does This Mean for Crypto?

Prospech finds dynamite heavy REE grades from historic core in Finland

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News